Loan Agreements in the Biotechnology Industry

1,212 Contracts & Agreements

Browse by Company

89bio, Inc. (5 contracts)
AbbVie Inc. (7)
ABEONA THERAPEUTICS INC. (2)
ACCELERON PHARMA INC (1)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (1)
Adamas Pharmaceuticals Inc (3)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (6)
ADMA BIOLOGICS, INC. (8)
AGENUS INC (1)
AgeX Therapeutics, Inc. (3)
Akebia Therapeutics, Inc. (5)
Akero Therapeutics, Inc. (2)
ALBIREO PHARMA, INC. (2)
Aldeyra Therapeutics, Inc. (11)
Alexion Pharmaceuticals (2)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (2)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (2)
Altimmune, Inc. (1)
ALX ONCOLOGY HOLDINGS INC (4)
AMARIN CORP PLC (1)
Amgen Inc. (2)
ANAPTYSBIO INC (3)
ANAVEX LIFE SCIENCES CORP. (5)
Apellis Pharmaceuticals, Inc. (1)
APPLIED GENETIC TECHNOLOGIES CORP (2)
Aptinyx Inc. (1)
AquaBounty Technologies, Inc. (2)
AQUINOX PHARMACEUTICALS, INC (1)
ARCA biopharma, Inc. (7)
Arcturus Therapeutics Holdings Inc. (4)
Arcus Biosciences, Inc. (1)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (8)
Arsanis, Inc. (9)
Athenex, Inc. (1)
aTYR PHARMA INC (5)
AVEO PHARMACEUTICALS INC (9)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (1)
AVROBIO, Inc. (2)
Axcella Health Inc. (5)
Axovant Sciences Ltd. (4)
AZIYO BIOLOGICS, INC. (6)
AzurRx BioPharma, Inc. (1)
BAKKEN RESOURCES INC (1)
BeiGene, Ltd. (3)
BELLICUM PHARMACEUTICALS, INC (7)
BICYCLE THERAPEUTICS Ltd (3)
BIOCEPT INC (6)
BioLife4D Corp (2)
BIOMARIN PHARMACEUTICAL INC (5)
BioRestorative Therapies, Inc. (2)
BIOVIE INC. (2)
BioXcel Therapeutics, Inc. (1)
bluebird bio, Inc. (5)
Blueprint Medicines Corp (2)
BridgeBio Pharma, Inc. (8)
CALADRIUS BIOSCIENCES, INC. (5)
CANCER GENETICS, INC (8)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (12)
Capstone Therapeutics Corp. (9)
CareDx, Inc. (4)
CASI Pharmaceuticals, Inc. (2)
CASTLE BIOSCIENCES INC (8)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (3)
Celcuity Inc. (3)
Celldex Therapeutics, Inc. (4)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (4)
Celsion CORP (6)
Century Therapeutics, Inc. (2)
Chardan Healthcare Acquisition Corp. (1)
Chelsea Worldwide Inc. (8)
ChemoCentryx, Inc. (8)
CHIMERIX INC (2)
Cidara Therapeutics, Inc. (7)
CLEVELAND BIOLABS INC (5)
Coherus BioSciences, Inc. (4)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (3)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (2)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
CTD HOLDINGS INC (19)
CTI BIOPHARMA CORP (8)
Cue Biopharma, Inc. (2)
Cyclacel Pharmaceuticals, Inc. (1)
Cytokinetics, Incorporated (10)
CytomX Therapeutics, Inc. (3)
CYTORI THERAPEUTICS, INC. (22)
CYTRX CORP (3)
DelMar Pharmaceuticals, Inc. (1)
Dermavant Sciences Ltd (1)
Dermira, Inc. (2)
Dicerna Pharmaceuticals Inc (2)
DYADIC INTERNATIONAL INC (1)
DYNAVAX TECHNOLOGIES CORP (5)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (5)
Eidos Therapeutics, Inc. (2)
Eiger BioPharmaceuticals, Inc. (9)
Elevation Oncology, Inc. (2)
Emerald Bioscience, Inc. (1)
Emergent BioSolutions Inc. (10)
Enochian Biosciences Inc (1)
Epizyme, Inc. (2)
Equillium, Inc. (4)
Esperion Therapeutics, Inc. (4)
Evelo Biosciences, Inc. (9)
EXACT SCIENCES CORP (4)
Exelixis (6)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (5)
FENNEC PHARMACEUTICALS INC. (4)
Finch Therapeutics Group, Inc. (1)
Foghorn Therapeutics Inc. (2)
Fortress Biotech, Inc. (1)
Frequency Therapeutics, Inc. (1)
Fusion Pharmaceuticals Inc. (3)
G1 Therapeutics, Inc. (5)
GALECTIN THERAPEUTICS INC (1)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (1)
GENOCEA BIOSCIENCES, INC. (8)
GERON CORP (4)
Gilead Sciences (1)
Global Blood Therapeutics, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (1)
GX Acquisition Corp. (5)
HALOZYME THERAPEUTICS INC (8)
HCW Biologics Inc. (1)
HEAT BIOLOGICS, INC. (10)
HilleVax, Inc. (3)
HISTOGENICS CORP (1)
Homology Medicines, Inc. (9)
HUMANIGEN, INC (18)
IMMUCELL CORP (8)
IMMUNE PHARMACEUTICALS INC (6)
Immune Therapeutics, Inc. (2)
IMPEL NEUROPHARMA INC (5)
INFINITY PHARMACEUTICALS, INC. (2)
Inhibikase Therapeutics, Inc. (4)
Inhibrx, Inc. (9)
Inmune Bio, Inc. (1)
Inozyme Pharma, Inc. (1)
INSMED Inc (6)
Instil Bio, Inc. (2)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (6)
Isoray, Inc. (3)
KalVista Pharmaceuticals, Inc. (5)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (3)
Kura Oncology, Inc. (7)
LEXICON PHARMACEUTICALS, INC. (13)
Ligand Pharmaceuticals Incorporated (13)
Locust Walk Acquisition Corp. (4)
LogicBio Therapeutics, Inc. (4)
MADRIGAL PHARMACEUTICALS, INC. (14)
MATEON THERAPEUTICS INC (3)
MEDICINOVA INC (1)
Medovex Corp. (2)
MERRIMACK PHARMACEUTICALS INC (8)
Mersana Therapeutics, Inc. (9)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (2)
MiMedx Group, Inc. (1)
Minerva Neurosciences, Inc. (5)
MIRAGEN THERAPEUTICS, INC. (4)
Molecular Templates, Inc. (4)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (15)
NEUROBIOLOGICAL TECHNOLOGIES INC (2)
NEWLINK GENETICS CORP (1)
NORTHWEST BIOTHERAPEUTICS INC (22)
NTN BUZZTIME INC (10)
Olema Pharmaceuticals, Inc. (2)
Olivia Ventures, Inc. (4)
Omega Therapeutics, Inc. (3)
OncoCyte Corp (3)
Oncorus, Inc. (1)
Ophthotech Corp. (1)
Opko Health, Inc. (3)
ORAGENICS INC (4)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (24)
PALATIN TECHNOLOGIES INC (1)
PhaseBio Pharmaceuticals Inc (3)
PIERIS PHARMACEUTICALS, INC. (3)
POLARITYTE, INC. (1)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (6)
PRECISION BIOSCIENCES INC (11)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
PREMIER BIOMEDICAL INC (1)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (1)
Propanc Biopharma, Inc. (7)
PROTEOSTASIS THERAPEUTICS, INC. (4)
PUMA BIOTECHNOLOGY, INC. (8)
Radius Health, Inc. (8)
Regulus Therapeutics Inc. (14)
RenovaCare, Inc. (9)
Replimune Group, Inc. (4)
Rezolute, Inc. (1)
RIGEL PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (3)
Sarepta Therapeutics, Inc. (1)
Savara Inc (13)
Scholar Rock Holding Corp (5)
SELECTA BIOSCIENCES INC (6)
SELLAS Life Sciences Group, Inc. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (3)
Sierra Oncology, Inc. (2)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (1)
SOLENO THERAPEUTICS INC (1)
SOLIGENIX, INC. (3)
SOPHIRIS BIO INC. (5)
Sorrento Therapeutics, Inc. (19)
Spectrum Pharmaceuticals, Inc. (1)
SPHERIX INC (1)
Spring Bank Pharmaceuticals, Inc. (3)
SPRUCE BIOSCIENCES, INC. (3)
Sun BioPharma, Inc. (5)
SUNESIS PHARMACEUTICALS INC (12)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (6)
Syndax Pharmaceuticals Inc (8)
Syros Pharmaceuticals, Inc. (4)
T2 Biosystems, Inc. (12)
Taysha Gene Therapies, Inc. (2)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (3)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (1)
Tracon Pharmaceuticals, Inc. (8)
TREVENA INC (6)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (2)
Twist Bioscience Corp (1)
U.S. Stem Cell, Inc. (15)
uniQure N.V. (7)
United Therapeutics Corp (1)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (6)
UroGen Pharma Ltd. (1)
Vaxart, Inc. (2)
VBI Vaccines Inc (4)
Vera Therapeutics, Inc. (2)
VERACYTE, INC. (3)
Verastem, Inc. (7)
Vericel Corp (6)
Viking Therapeutics, Inc. (4)
vTv Therapeutics Inc. (5)
Werewolf Therapeutics, Inc. (4)
WINDTREE THERAPEUTICS INC (20)
XBiotech Inc. (1)
Xenon Pharmaceuticals Inc. (3)
Xilio Therapeutics, Inc. (3)
XOMA Corp (14)
ZAFGEN, INC. (1)
Zai Lab Ltd (1)
ZIOPHARM ONCOLOGY INC (2)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

LOAN AGREEMENT

Loan Agreements

HEAT BIOLOGICS, INC.

Biotechnology

2013

Amendments to Revolving Credit, Term Loan and Security Agreement Still in Effect As of December 30, 2024

Loan Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Revolving Credit, Term Loan and Security Agreement by and among TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Berkshire Bank, dated...

Loan Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Termination of Securities Purchase, Loan and Security Agreement, dated November 13, 2024, by and between Capstone Holding Corp. and BP Peptides, LLC

Loan Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Fourth Amendment to Securities Purchase Loan and Security Agreement dated March 15, 2021, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC

Loan Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Third Amendment to Securities Purchase Loan and Security Agreement dated March 27, 2020, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC

Loan Agreements

Capstone Therapeutics Corp.

Biotechnology

2024

Loan and Security Agreement, dated December 20, 2024, by and among TScan Therapeutics, Inc. and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company

Loan Agreements

TScan Therapeutics, Inc.

Biotechnology

2024

Fifth Amendment to Loan and Security Agreement, dated December 4, 2024, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender

Loan Agreements

Syros Pharmaceuticals, Inc.

2024

Loan Agreement with Aggro Investments Pty Ltd dated December 3, 2024

Loan Agreements

Propanc Biopharma, Inc.

2024

Loan and Security Agreement by and between Silicon Valley Bank, a division of First-Citizens Bank & Trust Company and Tenaya Therapeutics, Inc

Loan Agreements

Tenaya Therapeutics, Inc.

2024

Loan & Security Agreement, between the Registrant, Hercules Capital, Inc. and the lenders listed therein, dated August 27, 2024

Loan Agreements

Arcus Biosciences, Inc.

2024

Loan Agreement, dated as of October 31, 2024, by and between Koligo Therapeutics, Inc., the Company and Yehuda Nir

Loan Agreements

Orgenesis Inc.

2024

Loan Extension Agreement, dated as of October 31, 2024, by and between Koligo Therapeutics, Inc., the Company and Yehuda Nir

Loan Agreements

Orgenesis Inc.

2024

PRECISION BIOSCIENCES, INC. AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

Loan Agreements

PRECISION BIOSCIENCES INC

2024

EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

Loan Agreements

PRECISION BIOSCIENCES INC

2024

Fourth Amendment to the Loan and Security Agreement dated October 29, 2024, by and between Ardelyx, Inc. and SLR Investment Corp

Loan Agreements

ARDELYX, INC.

2024

Amendment dated August 16, 2024 to the Loan Agreement dated August 21, 2023 by and between Celularity Inc. and the lender parties thereto

Loan Agreements

GX Acquisition Corp.

2024

Amendment to Loan and Security Agreement dated as of October 8, 2024

Loan Agreements

SOLIGENIX, INC.

2024

Second Amendment to Loan and Security Agreement, dated October 2, 2024, by and between Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, and Cue Biopharma,...

Loan Agreements

Cue Biopharma, Inc.

2024

Fourth Amendment to Loan and Security Agreement, dated September 30, 2024, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the several banks and other financial...

Loan Agreements

Aldeyra Therapeutics, Inc.

2024

Third Amendment to Supplement to Loan and Security Agreement, dated September 30, 2024, by and among Avenue Venture Opportunities Fund, L.P., Clene Inc. and Clene Nanomedicine, Inc

Loan Agreements

Chelsea Worldwide Inc.

2024

Fourth Amendment to Loan and Security Agreement, dated as of August 29, 2024, by and among the Company, the several banks and other financial institutions or entities party...

Loan Agreements

bluebird bio, Inc.

2024

Second Amendment to Amended and Restated Loan and Security Agreement, dated

Loan Agreements

Arcutis Biotherapeutics, Inc.

2024

Third Amendment to Loan and Security Agreement, dated as of August 13, 2024, by and among the Company, the several banks and other financial institutions or entities party...

Loan Agreements

bluebird bio, Inc.

2024

2024 Development Funding Loan Agreement, dated May 22, 2024, by and among Royalty Pharma Development Funding, LLC and the Company

Loan Agreements

Cytokinetics, Incorporated

2024

Third Amendment, dated May 22, 2024, to Development Funding Loan Agreement, dated January 7, 2022, by and among Royalty Pharma Development Funding, LLC and the Company

Loan Agreements

Cytokinetics, Incorporated

2024

Loan and Security Agreement, dated as of May 2, 2024, by and among the Registrant, each other person party thereto as a borrower from time to time, each person party thereto as a...

Loan Agreements

Werewolf Therapeutics, Inc.

2024

Fourth Amendment to Loan and Security Agreement, dated May 17, 2024, by and among the Registrant, Scholar Rock, Inc., Oxford Finance LLC and Silicon Valley Bank

Loan Agreements

Scholar Rock Holding Corp

2024

Loan Agreement dated June 3, 2024

Loan Agreements

Propanc Biopharma, Inc.

2024

First Amendment to Loan and Security Agreement by and between the Registrant and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, dated June 28, 2024

Loan Agreements

Olema Pharmaceuticals, Inc.

2024

Consent and Amendment No. 2 to Loan and Security Agreement, dated June 28, 2024, by and among uniQure biopharma, B.V., uniQure, Inc., uniQure IP B.V., the Company and Hercules...

Loan Agreements

uniQure N.V.

2024

Amended and Restated Loan and Security Agreement, entered into as of July 31, 2024, by and between Banc of California and Precision BioSciences, Inc

Loan Agreements

PRECISION BIOSCIENCES INC

2024

Eighth Amendment to Loan and Security Agreement, entered into as of June 21, 2024, by and between Banc of California (f/k/a Pacific Western Bank) and Precision BioSciences, Inc

Loan Agreements

PRECISION BIOSCIENCES INC

2024

Third Amendment to Loan and Security Agreement, dated April 29, 2024, by and among the Registrant, Helio Vision, LLC, the several banks and other financial institutions or...

Loan Agreements

Aldeyra Therapeutics, Inc.

2024

Loan Agreement, dated July 24, 2024, by and among USWM, LLC, as lender, and Panbela Therapeutics, Inc. and Cancer Prevention Pharmaceuticals, Inc., as borrowers

Loan Agreements

Sun BioPharma, Inc.

2024

Second Amendment to Loan and Security Agreement, dated as of July 9, 2024, by and among the Company, the several banks and other financial institutions or entities party thereto,...

Loan Agreements

bluebird bio, Inc.

2024

Loan Agreement dated July 3, 2024, by and among the Borrower and Yehuda Nir

Loan Agreements

Orgenesis Inc.

2024

Sixth Amendment to Loan and Security Agreement, dated June 28, 2024, with Oxford Finance, LLC and the lenders listed therein

Loan Agreements

LEXICON PHARMACEUTICALS, INC.

2024

Loan Agreement dated June 5, 2024

Loan Agreements

Propanc Biopharma, Inc.

2024

Loan Agreement dated June 3, 2024

Loan Agreements

Propanc Biopharma, Inc.

2024

Loan Agreement dated June 5, 2024

Loan Agreements

Propanc Biopharma, Inc.

2024